SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced its initial purchase of Bitcoin under its crypto reserve strategy targeting multi-chain asset growth. “Silo’s latest strategic crypto purchase signals our conviction in Bitcoin as both store of value and a hedge against general financial market volatility,” said Eric Weisblum, CEO of Silo. “Overall, ...

SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) --   Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced its initial purchase of Bitcoin under its crypto reserve strategy targeting multi-chain asset growth. “Silo’s latest strategic crypto purchase signals our conviction in Bitcoin as both store of value and a hedge against general financial market volatility,” said Eric Weisblum, CEO of Silo. “Overal ...

Company invests in DeSci blockchain innovation and purchases native coin of ResearchHub, a decentralized science platform co-founded by Coinbase CEO, Brian Armstrong SARASOTA, FL, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced its initial purchase of ResearchCoin (RSC) as part of its expanded digital assets treasury strategy designed to capture long-term va ...

SARASOTA, FL, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 2,857,143 shares of common stock at a purchase price of $0.875 per share. In a c ...

SARASOTA, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that it has entered into definitive agreements for the purchase and sale of 2,857,143 shares of common stock at a purchase price of $0.875 per share in a registered direct offering priced at-the-market under Nasdaq ...

Fireblocks is a globally recognized leader in the digital assets space, facilitating the secure transfer of more than $10 trillion to date SARASOTA, FL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, announced that it has begun implementing its strategic agreement with Fireblocks, an enterprise platform for secure digital asset custody, settlement, trading operations, and s ...

Core Viewpoint - Silo Wellness Inc. is transitioning to Born Defense Inc., focusing on defense innovation and national security investments, with a listing statement submitted to the Canadian Securities Exchange for review [1][3]. Company Overview - Silo Wellness Inc. will be renamed Born Defense Inc., which will operate as a national security investment issuer committed to ethical defense finance guided by the Just War Doctrine [9]. - The company's restructured business model will focus on trade finance, strategic equity investments, and collateral-backed lending for pre-IPO and critical infrastructure ventures globally [9]. Listing Statement Details - The Listing Statement provides comprehensive disclosure regarding the company's business, assets, financial statements, management team, and strategic direction, which is essential for resuming trading of the company's common shares [2]. - Recent measures to strengthen the financial position include agreements to settle approximately CAD $4.4 million of debt through the issuance of common shares, significantly reducing liabilities [4]. Strategic Direction - Born Defense's strategy is based on Just War principles, emphasizing the protection of individual liberty and responsible industrial stewardship [3]. - The company aims to stabilize and strengthen its public vehicle by converting debt into shares or establishing middle- and long-term payment plans with creditors [5]. Future Steps - The Listing Statement will be available on the company's profile on SEDAR+ once accepted for filing by the CSE, and shareholders will be notified of any required meetings to approve the proposed change of business [5].

Core Insights - Silo Pharma has engaged Fireblocks as the custodian for its institutional crypto treasury platform, focusing on Bitcoin, Ethereum, and Solana [1][2] - The partnership aims to ensure enterprise-grade security and governance standards for managing digital assets, enhancing long-term value for shareholders [2][3] Company Overview - Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, targeting underserved conditions such as stress-induced psychiatric disorders and chronic pain [3] - The company's therapeutic portfolio includes programs for PTSD, fibromyalgia, and preclinical assets for Alzheimer's disease and multiple sclerosis [3] Fireblocks Overview - Fireblocks is recognized for its secure platform that facilitates the transfer of over $6 trillion in digital assets, utilizing a multi-layer security framework [2][4] - The platform supports various financial entities, including exchanges, banks, and hedge funds, enabling them to scale their digital asset operations securely [4]

Core Insights - Silo Pharma Inc. has engaged Fireblocks as the custodian for its institutional crypto treasury platform, aiming to enhance security and governance standards [1][3] - Fireblocks has facilitated the secure transfer of over $6 trillion in digital assets, showcasing its capability in the digital asset space [2][3] - Silo Pharma's initial purchases of Ethereum (ETH) and Solana (SOL) tokens mark the beginning of its cryptocurrency treasury strategy, which was launched in August [5][6] Company Developments - The partnership with Fireblocks is expected to provide enterprise-grade security for Silo's crypto treasury platform [1][3] - Silo Pharma has appointed Corwin Yu as the first member of its Crypto Advisory Board to lead its cryptocurrency treasury strategy [5] - The company has also acquired AI-powered market intelligence technology to enhance decision-making capabilities [6] Market Context - The Fireblocks Network allows various financial entities, including exchanges and hedge funds, to securely scale their digital asset operations [4] - Silo Pharma's strategy aims to incorporate cryptocurrency into its treasury holdings and supports broader initiatives in blockchain and real-world asset tokenization [5]

Core Insights - The company has initiated its cryptocurrency treasury strategy by purchasing Ethereum (ETH) and Solana (SOL) tokens, marking a significant step towards integrating digital assets into its treasury holdings [2][3] - This investment reflects the company's belief in the long-term value of digital assets and the potential of blockchain technology to influence the biotechnology sector [2][3] - The CEO emphasized the company's commitment to decentralized finance and smart contract platforms, stating that the tokens will be staked for revenue generation and capital appreciation to support biopharmaceutical asset development [3] Company Overview - Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company focused on addressing underserved medical conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system diseases [4] - The company's portfolio includes innovative programs targeting PTSD, fibromyalgia, chronic pain, Alzheimer's disease, and multiple sclerosis, with research conducted in collaboration with leading universities and laboratories [4] Strategic Initiatives - The company's cryptocurrency treasury strategy aims for multi-chain asset growth and lays the groundwork for broader blockchain and real-world asset tokenization initiatives [2] - The accelerating adoption of digital assets by institutional investors and global enterprises supports the company's comprehensive digital assets strategy [3]